These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10918521)

  • 1. The PCR assay in the preclinical safety evaluation of nucleic acid medicines.
    Haworth R; Pilling AM
    Hum Exp Toxicol; 2000 May; 19(5):267-76. PubMed ID: 10918521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the toxicologic pathologist in the preclinical safety evaluation of biotechnology-derived pharmaceuticals.
    Pilling AM
    Toxicol Pathol; 1999; 27(6):678-88. PubMed ID: 10588549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical safety evaluation of human gene therapy products.
    Verdier F; Descotes J
    Toxicol Sci; 1999 Jan; 47(1):9-15. PubMed ID: 10048148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA vaccines: assay for integration into host genomic DNA.
    Ledwith BJ; Manam S; Troilo PJ; Barnum AB; Pauley CJ; Griffiths TG; Harper LB; Schock HB; Zhang H; Faris JE; Way PA; Beare CM; Bagdon WJ; Nichols WW
    Dev Biol (Basel); 2000; 104():33-43. PubMed ID: 11713822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens.
    Wang F; Patel DK; Antonello JM; Washabaugh MW; Kaslow DC; Shiver JW; Chirmule N
    Hum Gene Ther; 2003 Jan; 14(1):25-36. PubMed ID: 12573056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis.
    Appelt JU; Giordano FA; Ecker M; Roeder I; Grund N; Hotz-Wagenblatt A; Opelz G; Zeller WJ; Allgayer H; Fruehauf S; Laufs S
    Gene Ther; 2009 Jul; 16(7):885-93. PubMed ID: 19387483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment of biolistic DNA vaccination.
    Langer B; Renner M; Scherer J; Schüle S; Cichutek K
    Methods Mol Biol; 2013; 940():371-88. PubMed ID: 23104355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
    Serabian MA; Pilaro AM
    Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of IS1 transposition in plasmid amplification mutants of E. coli clones producing DNA vaccines.
    Prather KL; Edmonds MC; Herod JW
    Appl Microbiol Biotechnol; 2006 Dec; 73(4):815-26. PubMed ID: 16941177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients.
    Loudon PT; Blakeley DM; Boursnell ME; Day DA; Duncan IA; Lowden RC; McLean CS; Martin G; Miller JC; Shaw ML
    J Gene Med; 2001; 3(5):458-67. PubMed ID: 11601759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical development strategies for novel gene therapeutic products.
    Pilaro AM; Serabian MA
    Toxicol Pathol; 1999; 27(1):4-7. PubMed ID: 10367665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing attrition in drug development: smart loading preclinical safety assessment.
    Roberts RA; Kavanagh SL; Mellor HR; Pollard CE; Robinson S; Platz SJ
    Drug Discov Today; 2014 Mar; 19(3):341-7. PubMed ID: 24269835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time polymerase chain reaction in transfusion medicine: applications for detection of bacterial contamination in blood products.
    Dreier J; Störmer M; Kleesiek K
    Transfus Med Rev; 2007 Jul; 21(3):237-54. PubMed ID: 17572262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the clonal repertoire of gene-corrected cells in gene therapy.
    Paruzynski A; Glimm H; Schmidt M; Kalle Cv
    Methods Enzymol; 2012; 507():59-87. PubMed ID: 22365769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the safety of viral DNA vaccines: development of vectors containing both 5' and 3' homologous regulatory sequences from non-viral origin.
    Martinez-Lopez A; Encinas P; García-Valtanen P; Gomez-Casado E; Coll JM; Estepa A
    Appl Microbiol Biotechnol; 2013 Apr; 97(7):3007-16. PubMed ID: 23001057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development.
    Gonin P; Gaillard C
    Gene Ther; 2004 Oct; 11 Suppl 1():S98-S108. PubMed ID: 15454964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Integration of AAV vectors and insertional mutagenesis].
    Rossi A; Salvetti A
    Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assay.
    Lahijani R; Duhon M; Lusby E; Betita H; Marquet M
    Hum Gene Ther; 1998 May; 9(8):1173-80. PubMed ID: 9625256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion site pattern: global approach by linear amplification-mediated PCR and mass sequencing.
    Bartholomae CC; Glimm H; von Kalle C; Schmidt M
    Methods Mol Biol; 2012; 859():255-65. PubMed ID: 22367877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.